Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Foley

Showing results (61-70 of 185) with videos related to

Pageof 19
Sort By:
The Australasian Journal of Dermatology|April 22, 2020
Infliximab drug survival in chronic plaque psoriasis: follow-up of the product familiarisation programWilliam Berry, Benjamin Daniel, Rebecca Nguyen, et al.
Archives of Dermatology|March 8, 2003
The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap)Peter Foley, Yeqin Zuo, Anne Plunkett, et al.
The Australasian Journal of Dermatology|March 3, 2025
Drug Survival of Biological Therapies in Smokers and Non-Smokers With Psoriasis: A Retrospective Cohort Study Using Data From the Australasian Psoriasis RegistryFerial May, Julie Armstrong, Sara Vogrin, et al.
The Australasian Journal of Dermatology|March 29, 2020
Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseasesMarius Rademaker, Christopher Baker, Peter Foley, et al.
Dermatologic Therapy|September 10, 2021
Pityriasis rubra pilaris treatment options: A retrospective case series from a tertiary hospitalSarah Ringin, Christopher S Baker, Peter Foley, et al.
The Australasian Journal of Dermatology|August 9, 2021
Combination treatment with monoclonal antibodies: Secukinumab, benralizumab and dupilumab for the combined management of psoriasis and severe asthmaPatrick D Mahar, Celia M Zubrinich, Nick Manuelpillai, et al.
The Australasian Journal of Dermatology|May 30, 2024
Tildrakizumab use for recalcitrant pityriasis rubra pilarisZachary Holmes, Michelle S Goh, Peter Foley, et al.
The Australasian Journal of Dermatology|May 25, 2011
Thirty-five units of botulinum toxin type A for treatment of axillary hyperhidrosis in female patientsStefanie Marcella, Greg Goodman, Simon Cumming, et al.
The Australasian Journal of Dermatology|March 31, 2021
SARS-CoV-2 (COVID-19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology GroupCharlie Wang, Marius Rademaker, Bruce Tate, et al.
Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire|August 18, 2020
Prevalence of feline herpesvirus-1, feline calicivirus, <i>Chlamydia felis,</i> and <i>Bordetella bronchiseptica</i> in a population of shelter cats on Prince Edward IslandJulie Walter, Peter Foley, Carmencita Yason, et al.
Pageof 19

Showing results (61-70 of 185) with videos related to

Sort By:
Pageof 19
The Australasian Journal of Dermatology|April 22, 2020
Infliximab drug survival in chronic plaque psoriasis: follow-up of the product familiarisation programWilliam Berry, Benjamin Daniel, Rebecca Nguyen, et al.
Archives of Dermatology|March 8, 2003
The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap)Peter Foley, Yeqin Zuo, Anne Plunkett, et al.
The Australasian Journal of Dermatology|March 3, 2025
Drug Survival of Biological Therapies in Smokers and Non-Smokers With Psoriasis: A Retrospective Cohort Study Using Data From the Australasian Psoriasis RegistryFerial May, Julie Armstrong, Sara Vogrin, et al.
The Australasian Journal of Dermatology|March 29, 2020
Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseasesMarius Rademaker, Christopher Baker, Peter Foley, et al.
Dermatologic Therapy|September 10, 2021
Pityriasis rubra pilaris treatment options: A retrospective case series from a tertiary hospitalSarah Ringin, Christopher S Baker, Peter Foley, et al.
The Australasian Journal of Dermatology|August 9, 2021
Combination treatment with monoclonal antibodies: Secukinumab, benralizumab and dupilumab for the combined management of psoriasis and severe asthmaPatrick D Mahar, Celia M Zubrinich, Nick Manuelpillai, et al.
The Australasian Journal of Dermatology|May 30, 2024
Tildrakizumab use for recalcitrant pityriasis rubra pilarisZachary Holmes, Michelle S Goh, Peter Foley, et al.
The Australasian Journal of Dermatology|May 25, 2011
Thirty-five units of botulinum toxin type A for treatment of axillary hyperhidrosis in female patientsStefanie Marcella, Greg Goodman, Simon Cumming, et al.
The Australasian Journal of Dermatology|March 31, 2021
SARS-CoV-2 (COVID-19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology GroupCharlie Wang, Marius Rademaker, Bruce Tate, et al.
Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire|August 18, 2020
Prevalence of feline herpesvirus-1, feline calicivirus, <i>Chlamydia felis,</i> and <i>Bordetella bronchiseptica</i> in a population of shelter cats on Prince Edward IslandJulie Walter, Peter Foley, Carmencita Yason, et al.
Pageof 19